6-29173682-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_030905.3(OR2J2):āc.47T>Cā(p.Leu16Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,612,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030905.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR2J2 | NM_030905.3 | c.47T>C | p.Leu16Pro | missense_variant | 2/2 | ENST00000641417.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR2J2 | ENST00000641417.1 | c.47T>C | p.Leu16Pro | missense_variant | 2/2 | NM_030905.3 | P1 | ||
OR2J2 | ENST00000377167.3 | c.47T>C | p.Leu16Pro | missense_variant | 1/1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152000Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000121 AC: 3AN: 248184Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134688
GnomAD4 exome AF: 0.00000616 AC: 9AN: 1460770Hom.: 0 Cov.: 30 AF XY: 0.00000413 AC XY: 3AN XY: 726672
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152000Hom.: 0 Cov.: 31 AF XY: 0.0000539 AC XY: 4AN XY: 74226
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 23, 2023 | The c.47T>C (p.L16P) alteration is located in exon 1 (coding exon 1) of the OR2J2 gene. This alteration results from a T to C substitution at nucleotide position 47, causing the leucine (L) at amino acid position 16 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at